Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Advancing the Quality of Pediatric Antipsychotic Use: Maybe It Takes a PAL.

Literature DB >> 28297076

Advancing the Quality of Pediatric Antipsychotic Use: Maybe It Takes a PAL.

Julie Magno Zito¹.

Abstract

Mesh：

Substances：
Antipsychotic Agents

Year: 2017 PMID： 28297076 PMCID： PMC5346504 DOI： 10.1111/1475-6773.12671

Source DB: PubMed Journal: Health Serv Res ISSN： 0017-9124 Impact factor: 3.402

× No keyword cloud information.

13 in total

1. Implications of marked weight gain associated with atypical antipsychotic medications in children and adolescents.

Authors: Christopher K Varley; Jon McClellan
Journal: JAMA Date: 2009-10-28 Impact factor: 56.272

2. The effects of prior authorization policies on medicaid-enrolled children's use of antipsychotic medications: evidence from two mid-Atlantic states.

Authors: Bradley D Stein; Emily Leckman-Westin; Edward Okeke; Deborah M Scharf; Mark Sorbero; Qingxian Chen; Ka Ho Brian Chor; Molly Finnerty; Jennifer P Wisdom
Journal: J Child Adolesc Psychopharmacol Date: 2014-08-21 Impact factor: 2.576

3. Impact of the Florida Medicaid prior-authorization program on use of antipsychotics by children under age six.

Authors: Robert Constantine; Michael A Bengtson; Tanya Murphy; Marie McPherson; Ross Andel; Mary Elizabeth Jones; Christina Donaldson-Guenther
Journal: Psychiatr Serv Date: 2012-12 Impact factor: 3.084

4. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth.

Authors: William V Bobo; William O Cooper; C Michael Stein; Mark Olfson; David Graham; James Daugherty; D Catherine Fuchs; Wayne A Ray
Journal: JAMA Psychiatry Date: 2013-10 Impact factor: 21.596

5. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.

Authors: Christoph U Correll; Peter Manu; Vladimir Olshanskiy; Barbara Napolitano; John M Kane; Anil K Malhotra
Journal: JAMA Date: 2009-10-28 Impact factor: 56.272

Advancing the Quality of Pediatric Antipsychotic Use: Maybe It Takes a PAL.

1. Implications of marked weight gain associated with atypical antipsychotic medications in children and adolescents.

2. The effects of prior authorization policies on medicaid-enrolled children's use of antipsychotic medications: evidence from two mid-Atlantic states.

3. Impact of the Florida Medicaid prior-authorization program on use of antipsychotics by children under age six.

4. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth.

5. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.

6. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies.

7. National trends in the office-based treatment of children, adolescents, and adults with antipsychotics.

8. Weight gain and metabolic abnormalities during extended risperidone treatment in children and adolescents.

9. National trends in psychotropic medication polypharmacy in office-based psychiatry.

10. Second opinions improve ADHD prescribing in a medicaid-insured community population.

1. Pediatric Use of Antipsychotic Medications Before and After Medicaid Peer Review Implementation.